Psychiatry Conference: 14 To 16 October 2009, Rotorua

AUCKLAND, Oct. 14 /Medianet International-AsiaNet/ --

Pharmac Keen To Improve `Customer Participation'

Wellington, Oct 13 NZPA - Pharmac is asking for feedback on a range of options for improving its "customer participation".

Nz Medicines Terminology Recommendation Report Published

The Health Information Standards Office (HISO) this week released the New Zealand Medicines Terminology Recommendation Report.

New Medicines, Savings Result From Agreement

New funded treatments for HIV/AIDS and nausea, and a strengthened osteoporosis treatment have emerged from an agreement between PHARMAC and pharmaceutical company Merck Sharp & Dohme (MSD).

Mixed Feelings Greet New HIV Treatment

The New Zealand AIDS Foundation (NZAF) has welcomed the announcement that PHARMAC will subsidise ISENTRESS (raltegravir) from 1 October 2009.

Isentress Now Funded For NZ HIV Patients

New Zealand HIV patients will now have another fully funded treatment option thanks to PHARMAC reimbursing ISENTRESS (raltegravir) from 1 October 2009.

Cancer Society Calls For Pharmac Overhaul

Wellington, Sept 27 NZPA - The Cancer Society has called for an overhaul of Pharmac, the government's drug-buying agency.

RMI Members Help Pharmac Over Avoidable Medicine Shortage

The Researched Medicines Industry (RMI) says its members will be "calling in all the favours they can" from their international networks so patients are not left without medicines following a Medsafe ban on importing 20 PHARMAC-contracted generic medicines supplied by Apotex, a Canadian

Import Of Apotex Products Under Close Monitoring

This is an update to our release of Monday 14 September.

Medsafe Halts Canadian Medicines Imports

Wellington, Sept 17 NZPA - Medsafe says it has temporarily stopped importing medicines produced by Canadian company Apotex.

The Ministry of Health's drug regulatory arm said the halt followed a similar move in the United States last week.